Výsledky vyhledávání - "E C, Zwarthoff"

Absence of BRAF and HRAS mutations in eruptive Spitz naevi

Autor: S, Gantner, T, Wiesner, L, Cerroni, I, Lurkin, E C, Zwarthoff, M, Landthaler, C, Hafner

Publikováno v: The British journal of dermatology. 164(4)

Eruptive Spitz naevi have been reported rarely in the literature. In solitary Spitz naevi, BRAF and HRAS mutations, as well as increased copy numbers of chromosome 11p have been identified.To investigate the genetic changes underlying eruptive Spitz

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::bb69b559d98bccfe29bb6037697ce047
https://pubmed.ncbi.nlm.nih.gov/21418173

Zobrazit plný text záznamu

Expression of the MN1-TEL fusion protein in the human UCSD/AML1 leukemic cell line

Autor: L Guglielmi, Maryvonne Busson, Roland Berger, Olivier Bernard, E C Zwarthoff, V Della Valle

Publikováno v: Leukemia. 18(9)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5d411d201928357df9017601feb0ff8
https://pubmed.ncbi.nlm.nih.gov/15229617

Zobrazit plný text záznamu

Microsatellite analysis--DNA test in urine competes with cystoscopy in follow-up of superficial bladder carcinoma: a phase II trial

Autor: B W, van Rhijn, I, Lurkin, W J, Kirkels, T H, van der Kwast, E C, Zwarthoff

Publikováno v: Cancer. 92(4)

It has been shown that microsatellite analysis (MA) is able to detect bladder carcinoma in urine. Relatively small groups of patients often with high stage and grade disease were investigated. However, greater than 85% of cystoscopies are performed f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::54b51ee00b278c11608e196e3162a1e7
https://pubmed.ncbi.nlm.nih.gov/11550146

Zobrazit plný text záznamu

The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate

Autor: B W, van Rhijn, I, Lurkin, F, Radvanyi, W J, Kirkels, T H, van der Kwast, E C, Zwarthoff

Publikováno v: Cancer research. 61(4)

We analyzed the possible prognostic value of the recently discovered fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer. A FGFR3 mutation was found in 34 of 53 pTaG1-2 bladder cancers, whereas none of the 19 higher-staged tumors

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b8791bbb828122cb1774f82edeaf56f2
https://pubmed.ncbi.nlm.nih.gov/11245416

Zobrazit plný text záznamu

Evidence for a cytoskeleton attachment domain at the N-terminus of the NF2 protein

Autor: M A, den Bakker, P H, Riegman, A P, Suurmeijer, C J, Vissers, M, Sainio, O, Carpen, E C, Zwarthoff

Publikováno v: Journal of neuroscience research. 62(6)

Neurofibromatosis type 2 is a hereditary cancer syndrome characterized by the development of bilateral vestibular schwannomas. Underlying the disease are inactivating mutations of the NF2 tumor suppressor gene, located on chromosome 22, encoding a 59

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2d5c5cc88c6e6344bc4ef9127f33ae0d
https://pubmed.ncbi.nlm.nih.gov/11107160

Zobrazit plný text záznamu

Generation of antisera to mouse insulin-like growth factor binding proteins (IGFBP)-1 to -6: comparison of IGFBP protein and messenger ribonucleic acid localization in the mouse embryo

Autor: M, van Kleffens, C A, Groffen, N F, Dits, D J, Lindenbergh-Kortleve, A G, Schuller, S L, Bradshaw, J E, Pintar, E C, Zwarthoff, S L, Drop, J W, van Neck

Publikováno v: Endocrinology. 140(12)

The insulin-like growth factor (IGF) system is an important regulator of fetal growth and differentiation. IGF bioavailability is modulated by IGF binding proteins (IGFBPs). We have generated six different antisera, directed to synthetic peptide frag

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5488b13e2789f4b75d515aec1b08bf67
https://pubmed.ncbi.nlm.nih.gov/10579362

Zobrazit plný text záznamu

Loss of heterozygosity on chromosome 9 and loss of chromosome 9 copy number are separate events in the pathogenesis of transitional cell carcinoma of the bladder

Autor: A A, Van Tilborg, A C, Hekman, K J, Vissers, T H, van der Kwast, E C, Zwarthoff

Publikováno v: International journal of cancer. 75(1)

The most frequent genetic aberration found in transitional cell carcinoma (TCC) of the bladder involves chromosome 9. Loss of heterozygosity (LOH) analyses show deletions of both chromosome 9p and 9q, while in situ hybridization studies suggest a sig

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::19b6f7fa9377e9efe97a437dea152593
https://pubmed.ncbi.nlm.nih.gov/9426683

Zobrazit plný text záznamu

Neurofibromatosis type 2 protein co-localizes with elements of the cytoskeleton

Autor: M A, den Bakker, M, Tascilar, P H, Riegman, A C, Hekman, W, Boersma, P J, Janssen, T A, de Jong, W, Hendriks, T H, van der Kwast, E C, Zwarthoff

Publikováno v: The American journal of pathology. 147(5)

The product of the neurofibromatosis type 2 (NF2) tumor suppressor gene is a 595-amino-acid protein bearing resemblance to a family of band-4.1-related proteins. These proteins, including ezrin, radixin, and moesin, probably function as molecular lin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::cadc8ae6786063c4f10b241b90c15e40
https://pubmed.ncbi.nlm.nih.gov/7485397

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání